Objective: To apply next-generation sequencing (NGS) for the investigation of the genetic basis of undiagnosed muscular dystrophies and myopathies in a very large cohort of patients. Methods: We applied an NGS-based platform namedMotorPlex to our diagnostic workflow to test muscle disease genes with a high sensitivity and specificity for small DNA variants. We analyzed 504 undiagnosed patients mostly referred as being affected by limb-girdle muscular dystrophy or congenital myopathy. Results: MotorPlex provided a complete molecular diagnosis in 218 cases (43.3%). A further 160 patients (31.7%) showed as yet unproven candidate variants. Pathogenic variants were found in 47 of 93 genes, and in more than 30%of cases, the phenotype was nonconventional, broadening the spectrum of disease presentation in at least 10 genes. Conclusions: Our large DNA study of patients with undiagnosed myopathy is an example of the ongoing revolution in molecular diagnostics, highlighting the advantages in using NGS as a first-tier approach for heterogeneous genetic conditions.
The genetic basis of undiagnosed muscular dystrophies and myopathies / M. Savarese, G. Di Fruscio, A. Torella, C. Fiorillo, F. Magri, M. Fanin, L. Ruggiero, G. Ricci, G. Astrea, L. Passamano, A. Ruggieri, D. Ronchi, G. Tasca, A. D'Amico, S. Janssens, O. Farina, M. Mutarelli, V.S. Marwah, A. Garofalo, T. Giugliano, S. Sanpaolo, F. Del Vecchio Blanco, G. Esposito, G. Piluso, P. D'Ambrosio, R. Petillo, O. Musumeci, C. Rodolico, S. Messina, A. Evilä, P. Hackman, M. Filosto, G. Di Iorio, G. Siciliano, M. Mora, L. Maggi, C. Minetti, S. Sacconi, L. Santoro, K. Claes, L. Vercelli, T. Mongini, E. Ricci, F. Gualandi, R. Tupler, J. De Bleecker, B. Udd, A. Toscano, M. Moggio, E. Pegoraro, E. Bertini, E. Mercuri, C. Angelini, F.M. Santorelli, L. Politano, C. Bruno, G.P. Comi, V. Nigro. - In: NEUROLOGY. - ISSN 0028-3878. - 87:1(2016 Jul 05), pp. 71-76. [10.1212/WNL.0000000000002800]
The genetic basis of undiagnosed muscular dystrophies and myopathies
D. Ronchi;G.P. Comi;
2016
Abstract
Objective: To apply next-generation sequencing (NGS) for the investigation of the genetic basis of undiagnosed muscular dystrophies and myopathies in a very large cohort of patients. Methods: We applied an NGS-based platform namedMotorPlex to our diagnostic workflow to test muscle disease genes with a high sensitivity and specificity for small DNA variants. We analyzed 504 undiagnosed patients mostly referred as being affected by limb-girdle muscular dystrophy or congenital myopathy. Results: MotorPlex provided a complete molecular diagnosis in 218 cases (43.3%). A further 160 patients (31.7%) showed as yet unproven candidate variants. Pathogenic variants were found in 47 of 93 genes, and in more than 30%of cases, the phenotype was nonconventional, broadening the spectrum of disease presentation in at least 10 genes. Conclusions: Our large DNA study of patients with undiagnosed myopathy is an example of the ongoing revolution in molecular diagnostics, highlighting the advantages in using NGS as a first-tier approach for heterogeneous genetic conditions.
| File | Dimensione | Formato | |
|---|---|---|---|
|
Savarese et al - NEUROLOGY 2016.pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Dimensione
462.93 kB
Formato
Adobe PDF
|
462.93 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
|
PubMed_ComiRonchi_2016.pdf
Open Access dal 16/09/2017
Tipologia:
Publisher's version/PDF
Dimensione
406.49 kB
Formato
Adobe PDF
|
406.49 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
